Craft

PLx Pharma

Stock Price

$0

2023-06-14

Market Capitalization

$2.5 M

2023-06-14

Revenue

$8.2 M

FY, 2021

PLx Pharma Summary

Company Summary

Overview
PLx Pharma is a specialty pharmaceutical company focused on its clinically-validated PLxGuard drug delivery platform. It works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx's product pipeline also includes oral nonsteroidal anti-inflammatory drugs (NSAIDs). The company serves both the over-the-counter and prescription markets.
Type
Public
Status
Active
Founded
2002
HQ
Sparta, NJ, US | view all locations
Website
http://plxpharma.com/
Cybersecurity rating
Sectors

Key People

  • Natasha Giordano

    Natasha Giordano, President, CEO & Director

  • Michael Valentino

    Michael Valentino, Executive Chairman of the Board

  • Rita O'Connor

    Rita O'Connor, CFO & Head of Manufacturing and Supply Chain

  • Joanne Cotignola

LocationsView all

3 locations detected

  • Sparta, NJ HQ

    United States

    9 Fishers Ln suite c

  • Houston, TX

    United States

    8285 El Rio St #130

  • Woodmere, NY

    United States

    18 Lafayette Pl

PLx Pharma Financials

Summary Financials

Revenue (Q3, 2022)
$386.0K
Gross profit (Q3, 2022)
($1.1M)
Net income (Q3, 2022)
($8.5M)
Cash (Q3, 2022)
$25.8M
EBIT (Q3, 2022)
($10.8M)

Footer menu